Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
43
NCT01514123
Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 29, 2011
Completion: Nov 16, 2017